Robert J. Bitterman

2021

In 2021, Robert J. Bitterman earned a total compensation of $78.3K as President and Chief Executive Officer at RXi Pharmaceuticals.

Compensation breakdown

Salary$47,500
Stock Awards$30,800
Total$78,300

Bitterman received $47.5K in salary, accounting for 61% of the total pay in 2021.

Bitterman also received $30.8K in stock awards.

Rankings

In 2021, Robert J. Bitterman's compensation ranked 12,274th out of 12,415 executives tracked by ExecPay. In other words, Bitterman earned more than 1.1% of executives.

ClassificationRankingPercentile
All
12,274
out of 12,415
1st
Division
Manufacturing
5,440
out of 5,505
1st
Major group
Chemicals And Allied Products
2,355
out of 2,375
1st
Industry group
Drugs
2,078
out of 2,096
1st
Industry
Pharmaceutical Preparations
1,535
out of 1,546
1st
Source: SEC filing on June 9, 2023.

Bitterman's colleagues

We found two more compensation records of executives who worked with Robert J. Bitterman at RXi Pharmaceuticals in 2021.

2021

Gerrit Dispersyn

RXi Pharmaceuticals

Chief Executive Officer

2021

Geert Cauwenbergh

RXi Pharmaceuticals

Former interim Principal Executive and Financial Officer

News

You may also like